Lansoprazole overutilization: Methods for step-down therapy

American Journal of Managed Care

Volumn 9, Issue 5, 2003, Pages 353-358

  Pohland, Cynthia J ^a   Scavnicky, Stephanie A ^a   Lasky, Steve S ^a   Good, Chester B ^a  

^a Veteran's Affairs Pittsburgh Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ARTICLE; BARRETT ESOPHAGUS; CLINICAL TRIAL; COST CONTROL; DISEASE CONTROL; DRUG COST; DRUG DOSE REGIMEN; DRUG INDICATION; DRUG MEGADOSE; DRUG UTILIZATION; DUODENUM BLEEDING; GASTROESOPHAGEAL REFLUX; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HUMAN; INTERVIEW; LIFESTYLE; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL RECORD; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PRACTICE GUIDELINE; PREFERRED PROVIDER ORGANIZATION; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH HEMORRHAGE; SYMPTOM; ZOLLINGER ELLISON SYNDROME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-ULCER AGENTS; DRUG COSTS; DRUG UTILIZATION REVIEW; ENZYME INHIBITORS; FORMULARIES, HOSPITAL; GASTRIC ACID; GASTROENTERITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASES; HEALTH SERVICES MISUSE; HEALTH SERVICES RESEARCH; HOSPITALS, VETERANS; HUMANS; MEDICAL AUDIT; OMEPRAZOLE; PENNSYLVANIA; PROSPECTIVE STUDIES; PROTON PUMPS;

EID: 0038626737     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Top 2000 Drugs of 2000. Available at: www.rxlist.com/top200.htm. Accessed April 13, 2001.
2. Richardson P, Hawkey CJ, Stack WA, et al. Proton pump inhibitors: Pharmacology and rationale for use in gastrointestinal disorders. Drugs. 1998;56:307-335.
3. Hirschowitz B, Mohnen J, Shaw S. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h. Aliment Pharmacol Ther. 1996;10:497-506.
4. Agrawal NM, Campbell DR, Safdi MA, Lukasik NL, Huang B, Haber MM. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: Results of a double-blind randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group. Arch Intern Med. 2000;160:1455-1461.
5. Malesci A, Savarino V, Zentilin P, et al. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc. 1996;44:700-705.
6. Srinivasan R, Katz PO, Ramakrishnan A, Katzka DA, Vela MF, Castele DO. Maximal acid reflux control for Barrett's oesophagus: Feasible and effective. Aliment Pharmacol Ther. 2001;15:519-524.
7. Sampliner RE. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. Am J Gastroenterol. 1994;89:1844-1848.
8. Metz DC, Pisegna JR, Ringham GL, et al. Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome. Dig Dis Sci. 1993;38:245-256.
9. Van Rensburg CJ, Louw JA, Girdwood AH, Simjee AE, Marks IN. A trial of lansoprazole in refractory gastric ulcer. Aliment Pharmacol Ther. 1996;10:381-386.
10. Avner DL, Dorsch ER, Jennings DE, Greski-Rose PA. A comparison of three doses of lansoprazole (15, 30 and 60 mg) and placebo in the treatment of duodenal ulcer. The Lansoprazole Study Group. Aliment Pharmacol Ther. 1995;9:521-528.
11. Naunton M, Peterson GM, Bleasel MD. Overuse of the proton pump inhibitors. J Clin Pharm Ther. 2000;25:333-340.
12. Ashby K. Treatment of gastroesophageal reflux disease in a managed care environment. Am J Manag Care. 2000;6(suppl 9):S480-S483.
13. Hatlebakk JG, Katz PO, Camacho-Lobato L, Castell DO. Proton pump inhibitors: Better acid suppression when taken before a meal than without a meal. Aliment Pharmacol Ther. 2000;14:1267-1272.
14. Peghini PV, Katz PO, Castell DO. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects. Gastroenterology. 1998;115:1335-1339.
15. Department of Veterans Affairs Pharmacy Benefits Management Strategic Healthcare Group. The Pharmacologic Management of Gastroesophageal Reflux Disease. Washington, DC: Department of Veterans Health Administratio; September 1998. Publication # 98-0010, updated March 2000.
16. Murray MD, Kroenke K. Polypharmacy and medication adherence: Small steps on a long road. J Gen Intern Med. 2001;16:137-139.
17. American Gastroenterological Association medical position statement: Evaluation of dyspepsia. Gastroenterology. 1998;114:579-581.
18. Brandhagen DJ, Pheley AM, Onstad GR, Freeman ML, Lurie N. Omeprazole use at an urban-county teaching hospital. J Gen Intern Med. 1995;10:513-515.
19. Gebhard RL, Ho B, Toscano JP, et al. Appropriateness of long-term proton pump inhibitor prescribing practice in a tertiary care teaching hospital. Veterans Health Systems Journal. 2000;5:13-16.
20. Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterology. 2000;95:3118-3122.
21. Garrison MA, Gilbreath J, Lowe JS. Optimizing use of proton pump inhibitors. Federal Practitioner. 2001;18:26-29.
22. Inadomi JM, Jamal R, Murata GH, et al. Step-down management of gastroesophageal reflux disease. Gastroenterology. 2001;121:1095-1100.